Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials
(2008) European Urology — Vol. 53, n° 1, p. 6-9 (2008)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 87.57 KB
Details
- Authors
- Affiliations
Citations
Collette, L. (2008). Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials. European Urology, 53(1), 6-9. https://doi.org/10.1016/j.eururo.2007.08.041 (Original work published 2008)